Clik here to view.
Pharmalot.. Pharmalittle.. It’s the middle of the week…
pic thx to nicholas raymond on flickr creative commons Good morning, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? After all, consider the...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. Good Morning.. We’re catching up on Shire, J&J and…
pic thx to noel pennington on flickr creative commons Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that...
View ArticleClik here to view.
Pharmalot.. Pharmalittle.. We’re catching up on Pharma lobbying, Biogen and…
coffee thx to chichacha on flickr creative commons Good morning, everyone, and how are you today? We are just fine, thank you. In fact, we are thrilled to report that we have made it to the middle of...
View ArticleClik here to view.
Martin Shkreli may get competition for his pricey drug, after all
thx to william warby on flickr creative commons Thanks to a compounding pharmacy, Martin Shkreli’s company may no longer have a lock on the market for its pricey anti-infective drug Daraprim. A...
View ArticleClik here to view.
Will a compounded version of Martin Shkreli’s drug really make a difference?
thx to william warby on flickr creative commons When a compound pharmacy trumpeted plans last month to sell a cheap version of Martin Shkreli’s pricey anti-infective drug, the move was greeted with...
View ArticleClik here to view.
Pharmalot.. Pharmalot.. Good Morning.. Catching up on J&J, Mallinckrodt and..
pic thx to joanne on flickr creative commons Rise and shine, another busy day is on the way. And here on the Pharmalot campus, where clouds are hovering and leaves are falling, we are coping with our...
View Article
